Schedule 13D ownership disclosure

C4 Therapeutics Inc

Security class unavailable · CUSIP: 12529R107

Event date: 2020-10-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-20-271093
Form type
SC 13D
Filer
C4 Therapeutics, Inc.
CIK
CIK 1662579
Filed
Oct 16, 2020
Reporting period
Oct 06, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub